2008年

4th Asian Pacific Congress of Heart Failure, 1.31-2.3, Melbourne, Australia

  1. Matsumori A: European/Asian Heart Failure Summit the Regulatory environment in Europe & Asia. Is the bar too high for new HF therapies? Asian view
  2. Matsumori A: Lessons From Asia: Co joint Session With WHFS: Hepatitis C virus-associated heart failure
  3. Matsumori A: Genetics: Pathogenesis and treatment of cardiomyopathies

International Symposium on Cardiovascular and Neurovascular Medicine (ISCNM) in conjunction with International Heart Failure Symposium, 2.22-24, Hong Kong

Matsumori A: Role of inflammation in heart failure.

Heart Failure Society of India, 2.2-3.2, India

Matsumori A: Global alert and response network: Hepatitis C virus-derived heart disease

57th Annual Scientific Session, American College of Cardiology 2008, 3.29-4.1, Chicago, USA

  1. Matsumori A: Novel Immune Mechanisms of Dilated Cardiomyopathy, Mast cells and antihistamines in dilated cardiomyopathy.
  2. Bir S, Esaki J, Marui A, Sakaguchi H, Arai Y, Hirose K, Ikeda T, Tabata Y, Fujita M, Komeda M: A novel therapeutic angiogenesis with sustained delivery form of platelet-rich plasma in mouse hindlimb ischemia model.

17th Annual Scientific Meeting of the Indonesian Heart Association, 4.17-20, Jakarta

  1. Matsumori A: The role of ARBs in heart failure management
  2. Matsumori A: Global alert and response network for hepatitis C induced heart failure

World Congress of Cardiology 2008, 5.18-21, Buenos Aires, Argentina

  1. Matsumori A: APSC: Global burden of heart failure; Idiopathic heart failure: Contribution of cardiomyopathy and the global alert and response network
  2. Matsumori A: WHFS: The failing heart around the world: Heart failure due to virus infection in Asia
  3. Matsumori A: Pathogenesis beyond gene mutations, Understanding hypertrophic cardiomyopathy

The 11th Annual Toronto International Heart Failure Summit: From Pathophysiology to Clinical Practice, Together with The 2nd Annual International Congress of Cardiomyopathies and Heart Failure, 6.12-15, Toronto, Canada

  1. Matsumori A: Presidential Lecture: Global alert and response network. Cardiomyopathies and heart failure due to infections agents.
  2. Matsumori A: New classification of cardiomyopathies.

6th International Symposium on NT-proBNP, 6.18-19, Baveno, Italy

Matsumori A: NT-proBNP in infections myocarditis

The 4th China-Japan Cardiovascular Forum, 10.23-24, Beijing, China

Matsumori A: New classification of cardiomyopathies.

AHA/Japanese Circulation Society Joint Symposium: Cardiac Risk Prediction with Biomarkers: US and Japanese Populations. Scientific sessions, American Heart Association, 11.11, New Orleans, USA

Matsumori A: New Biomarkers: Free immunoglobulin light chains and anti-troponin I antibodies: Japanese perspective.

Concurrent Cardiovascular Meetings, 2.11-13, Washington, D.C, USA

  1. Kimura T: Current strategies and outcome of PCI for CTO in Japan
  2. Kimura T: Insight from the j-Cypher Registry Lont-term outcome of PCI using Sirolims-eluting Stent in Japan

13th Angioplasty Summit TCT Asia Pacific 2008, 4.23-25, Soul, Korea

  1. Kimura T:Live Case Transmission Cases#3,#4,#5(Operator)
  2. Kimura T:Real World Experience in J-Cypher Registy(Lecturer)
  3. Tada T,Toma M,Tazaki J,Hanazawa K,Saitoh N,Tamura T,Akao M,Kita T,Kimura T:Experience of novel filter device for distal protection Filtrap?TM
  4. Tazaki J,Tada T,Hanazawa K,Saitoh N,Tamura T,Toma M,Kimura T,Kita T:Mid-term Outcomes of two stent procedure with sirolimus-eluting stent in LMT bifurcation lesions.

GISE 2008 Congress, 9.23-26, Bologna, Italy

  1. Kimura T:Will Non-invasive Coronary Imaging Replace Invasive Imaging?
  2. Kimura T:Selection and Use of Guiding Catheters, Wires and Balloons

ENCORE SEOUL 2008, 9.26-27, Soul, Korea

Kimura T:Live Session Ⅶ(Live18)Complex lesion(Operator)

Transcatheter Cardiovascular Therapeutics, 10.12-17, Washington D.C., USA

Kimura T:Antiplatelet Therapy and Stent Thrombosis of Sirolimus-eluting Stent Insight from the j-Cypher Registry.

The 81th Scientific Sessions of American Heart Association, 11.8-12, New Orleans, USA

  1. Kimura T:Incidence and Outcome of Surgical Procedures After Sirolimus-eluting Stent Implantation(Poster Session)
  2. Kimura T:Antiplatelet Therapy and Stent Thrombosis After Sirolimus-eluting Stent Implantation(Oral Session)
  3. Tamura T,Mitsudo K,Kimura T,Morimoto T,Kadota K,on behalf of the j-CYPHER Registry investigators:Long-term Clinical Outcome and Predictor of Target Lesion Revascularization After Implantation of Sirolimus-Eluting Stent with Elective Two Stent Technique in Coronary Bifurcation Lesions.
  4. Kawashima T, Inuzuka Y, Kato T, Tamaki Y, Niizuma S, Iwanaga Y, Kita T, Shioi T: SIRT1 Overexpression Modulates Cardiac Metabolic Genes Expression and Induces Dilated Cardiomyopathy.
  5. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, Ohno S, Nishio Y, Tsuji K, Itoh H, Kimura T, Kita T, Horie M: A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation.
  6. Makiyama T, Akao M, Shizuta S, Doi T, Ohno S, Nishio Y, Tsuji K, Itoh H, Kimura T, Kita T, Horie M: SCN5A and Lamin A/C gene mutations are highly prevalent in patients with familial bradyarrhythmic disorders.
  7. Tsuji T, Akao M, Ishii T, Ashihara T, Makiyama T, Ohno S, Toyoda F, Nishio Y, Sakaguchi T, Matsuura H, Horie M: Identification and functional characterization of a novel intronic splicing mutation in KCNQ1 associated with long QT syndrome.
  8. Nagao K, Ono K, Horie T, Kojima Y, Nishi H, Kinoshita M, Kita T: Neural cell adhesion molecule is upregulated by metabolic stress and enhances the cardiomyocyte survival rate through neurite-cardiomyocyte communication.
  9. Horie T, Ono K, Iwanaga Y, Nishi H, Nagao K, Kinoshita M, Mori R, Hasegawa K, Kita T: NF-kB-dependent induction of microRNA-146 downregulates ErbB4 and may be involved in the deterioration of cardiomyocyte survival.
  10. Nishi H, Ono K, Kinoshita M, Nagao K, Horie T, Takanabe R, Hasegawa K, Iwanaga Y, Kita T: Upregulation of microRNA-27a, which downregulates retionoid X receptor a, controls cardiac myosin heavy chain gene expression in neonatal rat cardioyocyte.
  11. Takanabe R, Ono K, Takaya T, Horie T, Wada H, Kita T, Shimatsu A, Hasegawa K: Up-regulated expression of microRNA-143 in association with obesity in the adipose tissue of mice fed with high fat diet.
  12. Takaya T, Morimoto T, Sunagawa Y, Wada H, Kawamura T, Shimatsu A, Fujita M, Fujita Y, Sawamura T, Hasegawa K: Left ventricular expression of lectin-like oxidized low-density lipoprotein receptor-1 serves as a biomarker of heart failure in the salt-sensitive Dahl rat model of hypertension.
  13. Sunagawa Y, Morimoto T, Takaya T, Kawamura T, Wada H, Shimatsu A, Fujita M, Kita T, Hasegawa K: The kinase activity of cyclin-dependent kinase-9 is required for phosphorylation of p300 and its histone acetyltransferase activity during cardiomyocyte hypertrophy.
  14. Sunagawa Y, Morimoto T, Kawamura T, Takaya T, Wada H, Kuwaki T, Yanagi S, Sugimoto A, Tsukashita M, Marui A, Ikeda T, Shimatsu A, Fujita M, Kita T, Hasegawa K: Granulocyte-colony stimulating factor and erythropoietin synergistically improve left ventricular systolic function in heart failure after myocardial infarction in rats.
  15. Bir S, Marui A, Esaki J, Tsubota H, Fujita M, Tabata Y, Ikeda T: An evolving approach of therapeutic angiogenesis with sustained release of platelet-rich plasma in diabetic mouse hind limb ischemia.
  16. Bir S, Marui A, Esaki J, Yamahara K, Tsubota H, Fujita M, Tabata Y, Ikeda T: Sustained release of platelet-rich plasma, cocktail of potent angiogenic cytokines, restores blood perfusion by recruitment of bone marrow derived haematopoietic stem cells in the mouse hind limb ischemia.

The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit、3.29-4.1, Chicago, USA

  1. Tamura T,Mitsudo K,Kimura T,Kadota K,Investigators j-Cypher Registry:Long-Term Clinical Outcome of Sirolimus-Eluting Stent Implantation in Bifurcation Lesions from The j-Cypher Registry:Comparison of Simple versus Complex Stenting Techniques.
  2. Tamura T,Mitsudo K,Kimura T,Kadota K,Investigators j-Cypher Registry:Clinical and Angiographic Predictors of Restenosis and Target Lesion Revascularization After Implantation of Sirolimus-Eluting Stents in Bifurcation Lesions from the j-Cypher Registry.

第77回欧州動脈硬化学会(EAS), 4.26-29, Istanbul, Turkey

Mitsuoka H, Kume N, Jinnnai T, Aramaki Y, Toyohara M, Nishi H, Kita T:IL-18 stimulates release of soluble LOX-1 ? a possible mechanism in vulnerable plaques.

ESC Acute Cardiac Care 2008, 10.25-28, Versailles、France

Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T: Moderated Poster Session: Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) is a better prognostic biomarker for acute coronary syndrome than troponin T and C-reactive protein to predict recurrence or death.

European Society of Cardiology Congress 2008, 8.30-9.3, Munich, Germany

  1. Ohno S, Toyoda F, Zankov D, Makiyama T, Shimizu W, Miyamoto Y, Kamakura S, Matsuura H, Kita T, Horie M: Novel KCNE3 mutation reduced repolarizing potassium current and cause long QT syndrome.
  2. Watanabe S, Tamura T, Ono K, Kita T, Kimura T, Furukawa Y: IGF axis and adiponectin as prognostic markers of patients with congestive heart failure.
  3. Otsuka K, Terasaki F, Ikemoto M, Katashima T, Fujita S, Kanzaki Y, Sohmiya K, Kono T, Fujita M, Kitaura Y: Anti-inflammatory effects of S100A8/A9 (MRP8/14) on experimental autoimmune myocarditis by modulating proinflammatory cytokine network.
  4. Miyamoto S, Fujita M, Nohara R, Hosokawa R, Inoko N, Nagai K, Nakane E, Oba M, Ueyama K, Uehara K: Novel treatment with periodic acceleration with a horizontal motion platform for anginal patients.
  5. Miwa K, Fujita M: Low cardiac output in young adults with chronic fatigue syndrome and small heart.
  6. Katashima T, Terasaki F, Ikura Y, Otsuka K, Murakami S, Ikemoto M, Fujita M, Naruko T, Ueda M, Kitaura Y: Enhanced expression of myeloid-related protein complex (MRP8/14) in the myocardium of patients with acute myocardial infarction.
  7. Morimoto T, Fujita M, Sunagawa Y, Kawamura T, Takaya T, Wada H, Shimatsu A, Kita T, Hasegawa K: Curcumin, a natural p300-specific histone acetyltransferase inhibitor, prevents the development of cardiac hypertrophy in rats.

アメリカ腎臓学会、11.6-7、Philadelphia, USA

  1. Yanagita M: Recent progress on Tubulogenesis: A Role of BMP/BMP antagonist in Renal Development.
  2. Tanaka M: USAG-1, a novel BMP antagonist expressed in the kidney, exacerbates Alport glomeular pathogenesis
  3. Yamada S: Megalin binds to stress-inducible N-myc downstream-regulated gene 1 (NDRG1) in proximal tubules.

BMP conference Lake Tahoe、7.10、USA

Yanagita M:BMP/BMP antagoist during kidney disease and development

Keystone Symposia, 1.14-18, Colorado, USA

Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Miyamoto S, Nagasawa A, Yanagi S, Sugimoto R, Marui A, Komeda M, Fujita M, Shimatsu A, Kita T, Hasegawa K: Curcumin, a natural p300-specific histone acetyltransferase inhibitor, prevents the development of heart failure in rats

The 4th China-Japan Cardiovascular Forum (CJCF) 10.23-24, Beijing, China

Sunagawa Y, Morimoto T, Kawamura T, Takaya T, Wada H, Shimatsu A, Fujita M, Kita T, Hasegawa K: Cyclin dependent kinase-9 is required for histone acetyltransferase activity of p300 during cardiomyocyte hypertrophy

The 25th Annual Meeting of ISHR Japanese Section, 12.5-6, Yokohama, Japan

  1. Morimoto T, Sunagawa Y, Hasegawa K: A novel heart failure therapy that targets nuclear signaling pathway in cardiaomyocytes.
  2. Morimoto T, Sunagawa Y, Takaya T, Kita T, Shimatsu A, Fujita M, Hasegawa K: Curcumin Reverses the Hypertension-induced Left Ventricular Concentric Remodeling in Rats
  3. Kaichi S, Takaya T, Morimoto T, Sunagawa Y, Kawamura T, Ono K, Kita T, Heike T, Nakahata T, Hasegawa K: Cardiac-specific transcription in ES cells by Cdk9
  4. Kato T, Inuzuka Y, Tamaki Y, Kawashima T, Niizuma S, Okuda J, Iwanaga Y, Nrazaki M, Matsuda T, Soga T, Kita T, Shioi T. Metabolic Basis of the Transition from Cardiac Hypertrophy to Failure.
  5. Inuzuka Y, Kato T, Tamaki Y, Kawashima T, Niizuma S, Kita T, Shioi T. Long-term constitutive activation of insulin signaling induced maladaptive cardiac hypertrophy, but did not accelerate cardiac aging.
  6. Inuzuka Y, Kato T, Tamaki Y, Kawashima T, Niizuma S, Kita T, Shioi T. Inhibition of phosphoinositide-3-kinase attenuate age-dependent changes in murine heart.
  7. Kato T, Inuzuka Y, Tamaki Y, Kawashima T, Niizuma S, Okuda J, Iwanaga Y, Kita T, Soga T, Shioi T. Metabolic Profile of Liver from Rats with Hypertension and Heart Failure.

BIT Life Sciences' 1st Annual World Congress of Regenerative Medicine & Stem Cell, 2008, 12. 2-4, Guangzhou, China

Kaichi S, Takaya T, Morimoto T, Sunagawa Y, Kawamura T, Ono K, Kita T, Heike T, Nakahata T, Hasegawa K: Cyclin-dependent kinase-9, as a novel component of p300/GATA4 complex, is involved in the differentiation of mouse ES cells into cardiac myocytes.

Special Seminar at Wallenberg laboratory at University of Gothenburg, 2008, 8.29, Gothenburg, Sweden

Fujita M: Heparin potentiates coronary collateral arteriogenesis.


ページの先頭へ